JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mikosza, A. S. J.
Right arrow Articles by Hampson, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mikosza, A. S. J.
Right arrow Articles by Hampson, D. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2001, p. 347-350, Vol. 39, No. 1
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.1.347-350.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Comparative Prevalences of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli as Etiologic Agents of Histologically Identified Intestinal Spirochetosis in Australia

Andrew S. J. Mikosza,1 Tom La,1 W. Bastiaan de Boer,2 and David J. Hampson1,*

Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia 6150,1 and Department of Anatomical Pathology, PathCentre, Nedlands, Western Australia 6009,2 Australia

Received 20 April 2000/Returned for modification 29 September 2000/Accepted 19 October 2000

DNA from gastrointestinal biopsy specimens from 28 Australian patients with histologic evidence of intestinal spirochetosis (IS) was subjected to PCRs to amplify segments of the 16S rRNA and NADH oxidase genes of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli. B. aalborgi was identified in specimens from 24 (85.7%) patients and B. pilosicoli in those from 4 (14.3%) patients (2 of whom were also positive for B. aalborgi). For two patients, no product was amplified. This study demonstrates that B. aalborgi is much more commonly involved in histologically identified IS in Australian patients than is B. pilosicoli. This is the first report of amplification of B. pilosicoli DNA from humans with IS.

* Corresponding author. Mailing address: Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia 6150, Australia. Phone: 61 08 9360 2287. Fax: 61 08 9310 4144. E-mail: hampson{at}numbat.murdoch.edu.au.

Journal of Clinical Microbiology, January 2001, p. 347-350, Vol. 39, No. 1
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.1.347-350.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2001 by the American Society for Microbiology. All rights reserved.